Category: Anticoagulation
-
-
Save the date: Cardiometabolic grand round 6
March 2, 2022Save the date: the 6th cardiometabolic grand round
-
-
-
-
-
which prophylaxis? for whom? VTE prophylaxis panel discussion
January 26, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: which prophylaxis? for whom? VTE prophylaxis panel discussion
January 19, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
At a Glance: Approach to Ticagrelor-induced Dyspnea
January 2, 2022Managing dyspnea induced by Ticagrelor
-
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
January 2, 2022Umbrella H&S: session 4, secondary prevention of stroke
-
Umbrella Heart and Stroke: session 3, Atrial fibrillation screening
January 2, 2022Umbrella H&S: session 3, AF screening
-
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
January 2, 2022Umbrella H&S: session 2, carotid stenosis
-
Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO
January 2, 2022Umbrella H&S: session1, PFO
-
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
December 29, 2021Rivaroxaban vs Apixaban in AF
-
-
At a glance: preventing cardiovascular thrombotic event after ACS
December 21, 2021Ticagrelor in preventing post-ACS thrombotic events
-
HeartCast 1: practical approach to the treatment of HFrEF
December 15, 2021The first HeartCast: HFrEF management
-
-
-
Ticagrelor Hub: when to use and which dose?
November 28, 2021The dosage and indications of Ticagrelor
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
-
Save the date: Late-breaking Science in Cardiovascular disease prevention
October 19, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
-
-
-
Cardio-Watch Podcast: Episode 7, ESC 2021 special
September 20, 2021The seventh episode of Cardio-Watch: ESC 2021
-
-
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
September 17, 2021The role of Heparin in the management of thrombosis in COVID-19
-
-
-
-
-
-
-
-
-
-
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
-
Save the date: The first Umbrella event: chronic coronary syndrome
August 8, 2021First Umbrella session: CCS
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
-
Save the date: Anti-thrombotic lighthouse: navigating a new path to CAD management
August 2, 2021Anti-thrombotic lighthouse, 3rd session: anti-thrombotic therapy in CAD Cardio Calendar
-
-
Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19
July 31, 2021thromboprophylaxis in COVID-19
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
-
Save the date: Anti-Thrombotic Lighthouse (2nd session)
July 14, 20212nd session of Anti-Thrombotic Lighthouse: antiplatelet therapy in CCS
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
Safety and Efficacy of different antithrombotic strategies after TAVI
July 11, 2021Post-TAVI antithrombotic strategies
-
Save the date: Anti-Thrombotic Lighthouse (1st session)
June 26, 20211st session of Anti-Thrombotic Lighthouse: antiplatelet therapy in ACS
-
DiaBeat: The Beating Heart of Diabetes (6th session)
June 24, 20216th Diabetes Masterclass for Cardiologists
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
DCS 1400: session 8, Valvular Heart disease
June 16, 2021The eighth panel of DCS 1400: Valvular Heart disease
-
-
-
-
-
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
June 13, 2021The Third episode of Cardio-Watch: AF
-
Left Atrial Appendage Occlusion to prevent Stroke
June 9, 2021Preventing Stroke by surgical LA Appendage Occlusion
-
A review on four landmark anti-platelet therapy trials
June 1, 2021The latest updates on anti-platelet therapy from 4 important trials
-
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
May 20, 2021The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)
-
Impact: DAPT vs. Aspirin in patients with stroke or TIA
May 16, 2021A recent meta-analysis about antiplatelet therapy in stroke
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
-
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
-
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
March 11, 2021Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
December 7, 2020Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
-
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
December 3, 2020Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
-
Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)
November 30, 2020The effects of Ticarelor+ASA in Acute Stroke
-
-